169 related articles for article (PubMed ID: 32394398)
1. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration.
Ueno H; Kikumto M; Takebayashi Y; Ishibashi H; Takahashi T; Yasutomi H; Umemoto K; Nakamichi K; Saijo M; Ichinohe T; Maruyama H
J Neurovirol; 2020 Jun; 26(3):452-455. PubMed ID: 32394398
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.
Thurnher MM; Boban J; Rieger A; Gelpi E
AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
[TBL] [Abstract][Full Text] [Related]
3. A Punctate Magnetic Resonance Imaging Pattern in a Patient with Systemic Lupus Erythematosus Is an Early Sign of Progressive Multifocal Leukoencephalopathy: A Clinicopathological Study.
Ishii J; Shishido-Hara Y; Kawamoto M; Fujiwara S; Imai Y; Nakamichi K; Kohara N
Intern Med; 2018 Sep; 57(18):2727-2734. PubMed ID: 29709947
[TBL] [Abstract][Full Text] [Related]
4. Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy.
López Sala P; Alberdi Aldasoro N; Zelaya Huerta MV; Bacaicoa Saralegui MC; Cabada Giadás T
Radiologia (Engl Ed); 2020; 62(1):59-66. PubMed ID: 31375267
[TBL] [Abstract][Full Text] [Related]
5. Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Hodel J; Darchis C; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Zins M; Pruvo JP; Vermersch P; Leclerc X
Neurology; 2016 Apr; 86(16):1516-23. PubMed ID: 27009257
[TBL] [Abstract][Full Text] [Related]
6. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
7. Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question.
De Mercanti SF; Gned D; Matta M; Iudicello M; Franchin E; Clerico M
J Investig Med High Impact Case Rep; 2020; 8():2324709620939802. PubMed ID: 32646245
[TBL] [Abstract][Full Text] [Related]
8. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
[TBL] [Abstract][Full Text] [Related]
9. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
[TBL] [Abstract][Full Text] [Related]
10. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.
Mahajan KR; Amin M; Poturalski M; Lee J; Herman D; Zheng Y; Androjna C; Howell M; Fox RJ; Trapp BD; Jones SE; Nakamura K; Ontaneda D
Mult Scler; 2021 Dec; 27(14):2159-2169. PubMed ID: 33749379
[TBL] [Abstract][Full Text] [Related]
11. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation.
Lima MA; Hanto DW; Curry MP; Wong MT; Dang X; Koralnik IJ
J Neurovirol; 2005 Feb; 11(1):46-50. PubMed ID: 15804958
[TBL] [Abstract][Full Text] [Related]
12. Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.
Miyagawa M; Maeda M; Umino M; Kagawa K; Nakamichi K; Sakuma H; Tomimoto H
J Neurol Sci; 2014 Sep; 344(1-2):198-202. PubMed ID: 24972818
[TBL] [Abstract][Full Text] [Related]
13. Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.
Carra-Dalliere C; Menjot de Champfleur N; Deverdun J; Ayrignac X; Nerrant E; Makinson A; Casanova ML; Labauge P
J Neuroradiol; 2016 Feb; 43(1):6-10. PubMed ID: 26475668
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy.
Yokokawa K; Hisahara S; Matsuura Y; Ikeda K; Tsuda E; Saitoh M; Nakamichi K; Saijo M; Kamihara Y; Sato T; Kawamata J; Shimohama S
J Neurol Sci; 2016 Sep; 368():304-6. PubMed ID: 27538654
[No Abstract] [Full Text] [Related]
15. A case report of progressive multifocal leukoencephalopathy during steroid treatment for ANCA-associated renal vasculitis.
Tawara T; Kai H; Kageyama M; Akiyama T; Matsunaga T; Sakuma A; Ishii R; Tsunoda R; Kawamura T; Fujita A; Kaneko S; Morito N; Saito C; Usui J; Yamagata K
CEN Case Rep; 2020 Nov; 9(4):354-358. PubMed ID: 32388828
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy in multiple myeloma: a case report of a patient with SARS-CoV-2 infection and an updated systematic literature review.
Paolucci M; Gentile L; Gentile M; Borghi A; Merli E; Marchionni E; Guerra L; Galluzzo S; Cilloni N; Simonetti L; Zini A
Neurol Sci; 2023 Sep; 44(9):2995-2998. PubMed ID: 37421487
[TBL] [Abstract][Full Text] [Related]
17. Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
Ruiz-Heredia Y; Sanchez-Vega B; Barrio S; Linares M; Rapado I; Braggio E; Stewart K; Folgueira MD; Ramos A; Collado L; Ruiz J; Toldos O; Hernandez-Lain A; Martinez-Lopez J
J Oncol Pharm Pract; 2019 Jun; 25(4):998-1002. PubMed ID: 29690814
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
[TBL] [Abstract][Full Text] [Related]
19. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
